We Built Neurum Because Supplement Advice Is Broken

Most nootropic websites exist to sell you something. Articles are written by marketing teams, "research" cherry-picks favorable studies, and the recommendations always conveniently point to affiliate links. We thought people deserved better.

How We're Different

🔍

Research First, Always

Every claim on Neurum is traced back to published clinical research. We cite our sources, acknowledge limitations, and tell you when the evidence is weak.

🚫

No Affiliate Pressure

We do not let affiliate relationships influence what we recommend. If a product is bad, we say so -- even if saying so costs us revenue.

💬

Human Language

We explain the science the way a smart friend would -- clearly, honestly, and without jargon. You shouldn't need a PhD to understand what you're putting in your body.

⚠

Honest About Risks

Drug interactions, side effects, and quality red flags are never omitted. We tell you what could go wrong, not just what might go right.

Our Editorial Process

1

Research Collection

Our research team reviews systematic reviews, meta-analyses, and randomized controlled trials from PubMed, Cochrane, and other peer-reviewed databases.

2

Evidence Grading

Each claim is graded by evidence strength: strong (multiple RCTs), moderate (limited RCTs), emerging (pre-clinical or observational), or insufficient. We publish the grade.

3

Safety Review

Julian Chen reviews every dosing recommendation, drug interaction, and safety concern before publication. Products with inadequate safety data are flagged.

4

Human Translation

Sarah and the editorial team rewrite all content to be accessible, engaging, and actionable -- without sacrificing scientific accuracy.

5

Ongoing Updates

Articles are reviewed quarterly and updated when new research is published. We date-stamp every article so you know how current the information is.

"To empower individuals with scientific clarity, enabling safe and informed decisions about cognitive health -- without the hype, the hidden agendas, or the fine print."
-- The Neurum Team